Lv2
160 积分 2024-09-27 加入
Economic burden and cost drivers of interstitial lung disease: a systematic review
3个月前
已完结
ECONOMIC BURDEN OF ILLNESS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS UTILIZING TREATMENT COHORTS: A US RETROSPECTIVE CLAIMS STUDY
3个月前
已完结
Healthcare resource use and associated costs in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
3个月前
已完结